Abstract:OBJECTIVE:To evaluate the cure effectiveness and safety of sucrose gel in the treatment of bacterial vaginosis through a multi-center, randomized, double-blind, parallel controlled clinical study. METHODS:A clinical research method of multi-center, randomly double-blind, and dose group parallel comparison was adopted. In the study, 533 patients with bacterial vaginosis were randomly divided into two groups, which included 214 cases in the control group (5.0 g metronidazole gel) and 319 cases in the trial group (5.0 g sucrose gel ). The patients were treated with different medication according to the group where they were. All the cases in these two groups were treated with drugs vaginally twice in a day, morning and evening separately, for 5 days. The curative effect and safety evaluation were assessed from 7 to 10 days and 21 to 30 days after treatment respectively. RESULTS:The efficacy of the comprehensive clinical treatment showed that the cure rate of metronidazole gel group and sucrose gel group were 70.53% and 80.83% respectively 7 to 10 days after treatment. The recovery rate of Nugent score for vaginal smear were 71.50% and 81.15% respectively. The differences in the efficacy between these two groups were significant statistically (P<0.05). However, the cure rates of metronidazole gel group and sucrose gel group were 63.29% and 61.98% respectively 21 to 30 days after treatment. No statistically significant difference (P>0.05) could be found in the cure rates of the two groups. CONCLUSION:The clinical comprehensive efficacy and recovery of vaginal bacteria of sucrose gel group in the treatment of bacterial vaginosis were obviously superior to those of metronidazole gel 7 to 10 days after treatment. The susucrose gel could improve the clinical efficacy index and laboratory index of bacterial vaginosis. Other effects included the release of clinical symptoms, and the recovery of the normal micro-environment in the vagina according to the Nugent score. The curative efficacy of sucrose gel was equal to that of metronidazole gel 21 to 30 days after treatment. In the future, sucrose gel treatment can be a new strategy for the treatment of bacterial vaginosis. Various advantages can be taken to improve the cure rate of bacterial vaginosis and reduce the shortcomings produced by this disease.

[Sucrose Gel for the Treatment of Bacterial Vaginosis: a Phase II Clinical Trial].

[Sucrose Gel for Treatment of Bacterial Vaginosis: a Randomized, Double-Blind, Multi-Center, Parallel-Group, Phase III Clinical Trial].

Directed Shift of Vaginal Flora after Topical Application of Sucrose Gel in a Phase III Clinical Trial: a Novel Treatment for Bacterial Vaginosis.

Influence of nursing intervention on patients with recurrent bacterial vaginosis treated with sucrose gel

Clinical study of compound sea buckthorn oil suppository in the treatment of bacterial vaginosis

Efficacy and safety of different drugs for the treatment of bacterial vaginosis: a systematic review and network meta-analysis

Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota

Efficacy and safety of the combination nifuratel-nystatin and clindamycin-clotrimazole, in the treatment of bacterial vaginosis. Randomized controlled clinical trial

Analysis on the change of lactobacillus before and after treatment of SVVC patients with Canesten vaginal tablets and Micronazole vaginal soft capsules

[A Multicenter, Randomized, Open and Positive Parallel Controlled Clinical Study of Clotrimazole Vaginal Expansion Suppository and Vaginal Tablet in the Treatment of Mild and Moderate Vulvovaginal Candidiasis].

Efficacy and Safety of Fufang Furong Effervescent Suppository for the Treatment of Mixed Vaginitis: a Randomized, Multicenter, and Non-Inferiority Study

Clinical Effect and Safety of Miconazole Nitrate 1200 Mg in Treating Vulvovaginal Candidiasis

L-Se-methylselenocysteine loaded mucoadhesive thermogel for effective treatment of Vulvar candidiasis

Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis

Double-blind double-simulate randomized controlled clinical trial on secnidazole tablet in the treatment of trichomonal vaginitis

[Efficacy of 5-Nitroimidazole Derivatives in Treatment of Bacterial Vaginosis].

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)

Effectiveness of combined use of sodium bicarbonate sitz bath prescription and vaginal nystatin suppository in the treatment of patients with fungal vaginitis

The Efficacy and Safety of Clotrimazole Vaginal Tablet Vs. Oral Fluconazole in Treating Severe Vulvovaginal Candidiasis.

A Randomized Clinical Trial of the Efficacy and Safety of Terconazole Vaginal Suppository Versus Oral Fluconazole for Treating Severe Vulvovaginal Candidiasis.

Clinical Evaluation of Kangfute for Bacterial Vaginosis